At last year's Brainstorm Health conference in San Diego, Bergh found himself sitting at dinner with Othman Laraki, the cofounder and CEO of Color Genomics — a company that extracts the DNA from a customer's submitted saliva sample and then looks
for a set number of gene
mutations known to be associated with increased risk
for developing certain hereditary cancers or
heart conditions (depending on the test).